Ontario is establishing an expert advisory group to provide advice on follow-up care and treatment for people with multiple sclerosis (MS) who return to Ontario after undergoing the experimental Chronic Cerebro-Spinal Venous Insufficiency (CCSVI) procedure outside of Canada.
The expert advisory group will develop best practice guidelines on treatment for these patients and will provide these recommendations to the government. The members are:
- Dr. Barry Rubin, medical director of the Peter Munk Cardiac Centre
- Dr. Paul O'Connor, director of the MS Clinic at St. Michael's Hospital
- Dr. David Henry, president and CEO of the Institute of Clinical Evaluative Sciences
- Dr. Marcelo Kremenchutzky, director of the MS Clinic at London Health Sciences Centre
- Dr. Julian Spears, co-director of the neurovascular program at St. Michael's Hospital
- Dr. Liesly Lee, consultant neurologist at the Sunnybrook Health Sciences Centre and director of the Sunnybrook MS clinic
- Dr. Andreas Laupacis, executive director at Li Ka Shing Knowledge Institute at St. Michael's Hospital.
In keeping with the recommendation of the MS Society of Canada, Ontario would also support the federal government if it moves to create a national multiple sclerosis registry for patients living with MS.
Today's announcement is part of the government's Open Ontario Plan to provide more access to health care services while improving quality and accountability for patients.